Drug Discovery · Redwood City, CA · Founded 2019 · In IPO Registration
Developer of therapeutic medicines designed to provide curative treatments for serious viral and liver diseases. Bluejay Therapeutics is based in Redwood City, CA and was founded in 2019. Its last known valuation is $820 million. It has raised $243 million across 3 recorded rounds; the latest was an $182 million Series C in May 2024.
Last price · $/share
—
Implied valuation
$820.0M
Total raised
$243.0M
Last round
Later Stage VC (Series C)
May 2024
No prints on record
No secondary trades in Bluejay Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bluejay Therapeutics with a free account
·The complete investor list: 13 names
·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Bluejay Therapeutics stock.
